The aesthetic injectable market in India is expected to reach a projected revenue of US$ 205.5 million by 2033. A compound annual growth rate of 12.1% is expected of India aesthetic injectable market from 2026 to 2033.
Ipsen SA, AbbVie Inc, Merz Pharma, Galderma Group AG Registered Shares, Prollenium Medical Technologies, Suneva Medical, Sinclair Pharma plc, Medytox, Revance Therapeutics Inc
Other key industry trends
In terms of revenue, India accounted for 0.7% of the global aesthetic injectable market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Asia Pacific, China aesthetic injectable market is projected to lead the regional market in terms of revenue in 2033.
Vietnam is the fastest growing regional market in Asia Pacific and is projected to reach USD 72.1 million by 2033.
India’s aesthetic injectable market is expected to be driven by the increasing affordability of aesthetic procedures, growing disposable income, and rising awareness about these procedures. According to the ISAPS 2022 report, nearly 176,899 injectable procedures were performed in the country, with 96,368 botulinum toxin procedures and around 71,734 HA injection procedures.
Easy accessibility of cosmetic clinics, growing awareness about procedures through social media, rising disposable income, and growing awareness about various cosmetic procedures are likely to drive the market.
Moreover, lower treatment costs in the country are expected to contribute to the growing medical tourism. According to an article by XE.com, Inc. in 2019, the cost of aesthetic procedures in India is about one-tenth of that in the U.S.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Aesthetic Injectable Market will help companies and investors design strategic landscapes.
Hyaluronic Acid was the largest segment with a revenue share of 54.21% in 2025.
Horizon Databook has segmented the India aesthetic injectable market based on collagen and pmma microspheres, hyaluronic acid, calcium hydroxylapatite (caha), plla, pcl, pn/pdrn, botulinum toxin (botox) covering the revenue growth of each sub-segment from 2021 to 2033.
India’s aesthetic injectable market is expected to be driven by the increasing affordability of aesthetic procedures, growing disposable income, and rising awareness about these procedures. According to the ISAPS 2022 report, nearly 176,899 injectable procedures were performed in the country, with 96,368 botulinum toxin procedures and around 71,734 HA injection procedures.
Easy accessibility of cosmetic clinics, growing awareness about procedures through social media, rising disposable income, and growing awareness about various cosmetic procedures are likely to drive the market.
Moreover, lower treatment costs in the country are expected to contribute to the growing medical tourism. According to an article by XE.com, Inc. in 2019, the cost of aesthetic procedures in India is about one-tenth of that in the U.S.
India Aesthetic Injectable Market Product Outlook (Revenue, USD Million , 2021-2033)
Collagen and PMMA Microspheres
Hyaluronic Acid
Calcium Hydroxylapatite (CaHA)
PLLA
PCL
PN/PDRN
Botulinum Toxin (Botox)
India Aesthetic Injectable Market Application Outlook (Revenue, USD Million , 2021-2033)
Wrinkle Correction
Lip Augmentation
Facial Contouring
Scar Treatment
Volume Loss Restoration
Others
India Aesthetic Injectable Market End Use Outlook (Revenue, USD Million , 2021-2033)
MedSpas
Aesthetic Surgery Centers
Hospitals
Others
Reasons to subscribe to Aesthetic Injectable Market databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Aesthetic Injectable Market databook
Our clientele includes a mix of Aesthetic Injectable Market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the India Aesthetic Injectable Market, including forecasts for subscribers. This country databook contains high-level insights into India Aesthetic Injectable Market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
India Aesthetic Injectable Market, 2021-2033 (US$M)